Longevity Variant Database

Narrow results by variant, study, or associated fields (e.g. gene symbol ADRB2):

Use ontology terms to further narrow results (e.g. aging, insulin, etc.):


  • Variant type: + -

  • 1 2 3 4 5 6 7 8 9 10 11 12
    13 14 15 16 17 18 19 20 21 X Y MT
    Export results (Download)

    Populations | Study Types | Variant Types



    LVDB_word_cloud.png
    logo.png
    variants.jpg
    polymorphism factor odds ratio pvalue initial number replication number Population age of cases shorter lived allele longer lived allele study type reference
    rs2075650 APOE 0.000527 1364 American, British Age range 50-108; mean age at death 80.2 C T Candidate Region/Gene 22445811
    rs429358 + rs7412 APOE 0.04 1236 vs 326 Chinese 60+ e4 non-e4 Candidate Region/Gene 9792194
    - APOC1 0.05 282 vs 200 British 84 and over Candidate Region/Gene 9105559
    Apo C-I 1>2 Apo C-I 0.05 282 vs 200 British 84+ Apo C-I 2 Candidate Region/Gene 9105559
    APOE e2,e3,e4 APOE 9.24 0.01 224 vs 441 Ashkenazi Jewish 75 e4 e2 Candidate Region/Gene 15621215
    APOE e2/e3/e4 APOE 4.40 0.02 179 Finn Minimum age 104 e3, e4 e2 Candidate Region/Gene 11213279
    APOE e2/e4 APOE 2.00 0.001 300 vs 160 French 100+ e4 e2 Candidate Region/Gene 8136829
    APOE haplotype - rs1346044 APOE 0.0001 175 vs 178 Finn 100.8 e4 e2 Candidate Region/Gene 10069711
    apoE haplotypes APOE 0.013 35 old vs 71 young vs 54 MI patients Chinese 90 apoE4 ApT4 Candidate Region/Gene 11780357
    apoE haplotypes APOE 0.013 35 old vs 71 young vs 54 MI patients Chinese 90 apoE4 Candidate Region/Gene 11780357
    APOE polymorphism APOE 0.0001 291 vs 589 Finn Mean age 97.5 e4 e2 Candidate Region/Gene 16487435
    APOE polymorphism APOE 0.38 0.002 200 (cases) vs 539 Italian >88 e4 e2 Candidate Region/Gene 21703254
    APOE polymorphism APOE 0.02 80 vs 391 Greek >80 epsilon4 Candidate Region/Gene 17234815
    APOE4 APOE 0.013 35 vs 125 Chinese 90 years or over High E4 frequency Candidate Region/Gene 11780357
    APOE4 APOE 0.71 106 vs 349 American 70-79 (duration of study - 7 years) e4 Candidate Region/Gene 16799145
    E2 / E3 / E4 APOE 1.2e-08 560 vs 560 French centenarians 100th year or beyond, mean age 103.1 E4 Candidate Region/Gene 11280044
    E4 APOE 0.013 35 vs 125 Chinese 90 years or over Candidate Region/Gene 11780357
    epsilon2/3/4 APOE 0.05 67 vs 125 Italian 99+ (mean: 100±2) epsilon4 Candidate Region/Gene 10643896
    KIR2DS3 haplotypes KIR2DS3 0.05 100 vs 100 Irish Age range: 65-99 Candidate Region/Gene 21299522
    Lys751Gln ERCC2 0.017 149 vs 413 Polish Mean age 101.1 homozygous (Lys/Lys, Gln/Gln) heterozygous (Lys/Gln) Candidate Region/Gene 19707883
    rs10412199 ATCAY 0.91 3.02e-06 5974 (RS), 3267 (CHS), 3136 (FHS), 4511 (ARIC), 3219 (AGES), 902 (inCHIANTI), 620 (BLSA), 1661 (HABC), 1717 (SHIP) Whitehall II - 6000 (UK), English Longitudinal Study of Ageing (UK), Religious Order Study - 1100, Memory and Ageing Project American A Genome-Wide Association Study 21782286
    rs11086106 PGPEP1 1.77 0.000263101 801 vs 914 Caucasian Median age 104 A G Genome-Wide Association Study 22279548
    rs1674159 NDUFA11 1.41 0.000520159 801 vs 914 Caucasian Median age 104 G A Genome-Wide Association Study 22279548
    rs1800471 TGFB1 0.034 172 vs 247 Italian 90-103 GC (genotype) Candidate Region/Gene 15569360
    rs2075650 APOE 0.71 3.39e-17 403 vs 1670 4149 vs 7582 Dutch mean 94 e4 Genome-Wide Association Study 21418511
    • Page 1 of 2
    • 25 of 46 variants

    The Longevity Variant Database (LVDB) is a collaborative effort to catalogue all published genetic variants relevant to human longevity.

    The project is directed by the Health Extension Research Foundation [http://www.healthextension.co/about/], and the online content is managed by the members of the Global Computing Initiative.

    LVDB is driven by an international collaboration of scientists, programmers, and volunteers, including Joe Betts-LaCroix, Kristen Fortney, Daniel Wuttke, Eric K. Morgen, Nick Schaum, John M. Adams, Jessica Choi, Barry Goldberg, Amir Levine, Maria Litovchenko, Aiste Narkeviciute, Emily Quist, Navneet Ramesh, Justin Rebo, Dmitri Shytikov, and Jimi Vyas. o


    Suggest a new study Report a database issue